Celator Pharma Balance Sheet - Annual (NASDAQ:CPXX)

Add to My Stocks
$30.24 $0 (0%) CPXX stock closing price Jul 14, 2016 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Celator Pharma stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Celator Pharma stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Celator Pharma had a long term debt of $9.49M at the end of 2015. To understand the debt servicing capacity of the company, one needs to look at Celator Pharma operating cash flow and Celator Pharma revenue also. Celator Pharma debt to equity ratio is .

View latest 10 year balance sheet data to check Celator Pharma financial performance.
show more
Fiscal year is Jan - Dec20152014201320122011
Marketable Securities-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets--1.03M--
Total Current Assets
Property Plant & Equipment2.15M2.15M2.18M2.25M4.23M
Accumulated Depreciation1.29M1.15M1.04M1.01M2.21M
Net Property Plant & Equipment
Investment & Advances-----
Other Non-Current Assets-----
Deferred Charges-----
Deposits & Other Assets-----
Total Assets
Notes Payable-----
Accounts Payable--1.19M--
Current Portion Long-Term Debt5.37M--1.2M2.1M
Current Portion Capital Leases-----
Accrued Expenses2.37M1.73M1.63M1.19M-
Income Taxes Payable-----
Other Current Liabilities-----
Total Current Liabilities
Deferred Taxes/Income1.02M--1.07M-
Convertible Debt-----
Long-Term Debt9.49M9.83M-1.8M-
Non-Current Capital Leases-----
Other Long-Term Liabilities-----
Total Liabilities
Minority Interest-----
Preferred Stock-----
Common Stock Net-----
Capital Surplus175.22M171.28M155.95M118.5M104.38M
Retained Earnings-168.68M-149.36M-132.46M-111.62M-100.71M
Treasury Stock-----
Other Liabilities-0.05M-0.05M-0.05M-0.05M-1.12M
Shareholders Equity6.53M21.9M23.46M6.85M2.56M
Total Liabilities & Shareholders Equity25.63M35.11M27.47M13.43M6.62M
All figures in USD. M: Millions of USD, B: Billions of USD.

Most investors just check the Celator Pharma stock price, and Celator Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Celator Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Celator Pharma owns and has monetary significance. CPXX assets decreased from $35.11M in 2014 to $25.63M in 2015. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Celator Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for CPXX stock stand at $19.1M.